Cargando…
Formulation and pharmacokinetic evaluation of a paclitaxel nanosuspension for intravenous delivery
Paclitaxel is a diterpenoid isolated from Taxus brevifolia. It is effective for various cancers, especially ovarian and breast cancer. Due to its aqueous insolubility, it is administered dissolved in ethanol and Cremophor(®) EL (BASF, Ludwigshafen, Germany), which can cause serious allergic reaction...
Autores principales: | Wang, Yonglu, Li, Xueming, Wang, Liyao, Xu, Yuanlong, Cheng, Xiaodan, Wei, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141875/ https://www.ncbi.nlm.nih.gov/pubmed/21796250 http://dx.doi.org/10.2147/IJN.S21097 |
Ejemplares similares
-
Study on Formulation, in vivo Exposure, and Passive Targeting of Intravenous Itraconazole Nanosuspensions
por: Yuan, Qi, et al.
Publicado: (2019) -
Itraconazole nanosuspension for oral delivery: Formulation, characterization and in vitro comparison with marketed formulation
por: Nakarani, M., et al.
Publicado: (2010) -
Formulation and evaluation of docetaxel nanosuspensions: In-vitro evaluation and cytotoxicity
por: Ibrahim, Mohamed A., et al.
Publicado: (2019) -
Pharmacokinetic evaluation of a 1,3-dicyclohexylurea nanosuspension formulation to support early efficacy assessment
por: Wahlstrom, Jan L, et al.
Publicado: (2007) -
Preparation, characterization and pharmacokinetics of cyadox nanosuspension
por: Sattar, Adeel, et al.
Publicado: (2017)